For more information1.800.263.0016

Products

TD NANO-EMULSION SR

Introduction

TD Nano-Emulsion SR is a breakthrough compounding base for the transdermal delivery of lipophilic active pharmaceutical ingredients (APIs) up to 24 hours (studied). TD Nano-Emulsion SR is the first sustained release transdermal delivery cream base. You can easily incorporate Pharmaceutical active ingredients into the base by using manual and/or electronic mortar and pestle (Unguator). This cream base is salt stable and it contains an anti-oxidant.

Available Sizes:

100G, 500G, 18 KG

Where to buy

TD Nano-Emulsion SR Highlighted Benefits

  •  Salt Stable
  • Contains an Anti-oxidant
  • Simple Compounding Process
  • Sustains the Release of Lipophilic APIs up to 24 hours

Applications

  • Sustained Pain Management
  • Sustained HRT
  • Sustained Anti-Oxidant Delivery

API Compatibility Chart

APIs

%

APIs

%

Amitriptyline HCl

0.5-4

Ketamine

5-10

Baclofen

5

Ketoprofen

10-20

Benzoocaine

2-20

Menthol

1-5

Camphor

2

Methyl Salicylate

5-15

Cyclobenzaprine HCl

0.5-2

Nifedipine

0.2

Diclofenac Sodium

10-20

Piroxicam

0.5-2

Gabapentin

6

Prilocaine

2-10

Ibuprofen

2-20

Tetracaine

2-10

Lidocaine

2-10

Tramadol

2-5

***The above recommended concentrations are for transdermal application. The concentration is required to be adjusted for any other route of administration such as mucosal, vaginal or rectal delivery.

Compatible Wetting Agents

Ethoxy Diglycol, Glycerin, Propylene Glycol, Isopropyl Alcohol, MCT Oil, Octyl Dodecanol & Water.

 

TD Nano-Emulsion SR Physicochemical Characteristics

 

pH

 4.5 – 5.5

Specific Gravity

0.99-1.05 

Color

White

Dosage Form

Cream

 

Disclaimer: Transderma Pharmaceuticals Inc. has provided the formula and instructions above as a model for educational purposes only on the basis of recognized compendia and texts or references. Transderma Pharmaceuticals Inc. takes no responsibility for the validity or accuracy of this information or for its safety or effectiveness, nor for any use thereof, which is at the sole risk of the licensed pharmacist. Adjustments may be needed to meet specific patient needs and in accordance with a licensed prescriber’s prescription. The pharmacist must employ appropriate tests to determine the stability of this suggested formula. Transderma Pharmaceuticals Inc., its owners, officers, agents, contractors, affiliates and employees cannot be held liable to any person or entity concerning claims, loss or damage caused by, or alleged to be caused by, directly or indirectly, the use or misuse of the information contained in this suggested formula. In all cases, it is the responsibility of the licensed pharmacist to know the law, to compound any finished product and to dispense these products in accordance with Health Canada and FDA guidelines and appropriate Provincial Drug Schedules and Provincial or Territorial Pharmacy Practice Standards.